TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients

T. L. Lasho, Ayalew Tefferi, J. D. Hood, S. Verstovsek, D. G. Gilliland, Animesh D Pardanani

Research output: Contribution to journalArticle

87 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1790-1792
Number of pages3
JournalLeukemia
Volume22
Issue number9
DOIs
StatePublished - 2008

Fingerprint

Thrombopoietin Receptors
Pyrrolidines
Janus Kinase 2
Cultured Tumor Cells
Myeloproliferative Disorders
Erythroid Cells
Sulfonamides
Exons
Cell Proliferation
Mutation
TG101348

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

@article{2d73188a531740f88f84751844eb5767,
title = "TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients",
author = "Lasho, {T. L.} and Ayalew Tefferi and Hood, {J. D.} and S. Verstovsek and Gilliland, {D. G.} and Pardanani, {Animesh D}",
year = "2008",
doi = "10.1038/leu.2008.56",
language = "English (US)",
volume = "22",
pages = "1790--1792",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients

AU - Lasho, T. L.

AU - Tefferi, Ayalew

AU - Hood, J. D.

AU - Verstovsek, S.

AU - Gilliland, D. G.

AU - Pardanani, Animesh D

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=49449100990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449100990&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.56

DO - 10.1038/leu.2008.56

M3 - Article

C2 - 18354492

AN - SCOPUS:49449100990

VL - 22

SP - 1790

EP - 1792

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 9

ER -